HWCI - Multispecialty Grand Rounds Evaluation - September 14, 2026

Please select one: *

I am in active clinical practice

I am retired

I am a student

Other

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Describe the role of cardiovascular risk assessment and surveillance before, during, and after cancer treatment.	Describe the role of cardiovascular risk assessment and surveillance before, during, and after cancer treatment. - 5	Describe the role of cardiovascular risk assessment and surveillance before, during, and after cancer treatment. - 4	Describe the role of cardiovascular risk assessment and surveillance before, during, and after cancer treatment. - 3	Describe the role of cardiovascular risk assessment and surveillance before, during, and after cancer treatment. - 2	Describe the role of cardiovascular risk assessment and surveillance before, during, and after cancer treatment. - 1
Recognize common cardiovascular complications associated with contemporary cancer therapies and select appropriate diagnostic strategies.	Recognize common cardiovascular complications associated with contemporary cancer therapies and select appropriate diagnostic strategies. - 5	Recognize common cardiovascular complications associated with contemporary cancer therapies and select appropriate diagnostic strategies. - 4	Recognize common cardiovascular complications associated with contemporary cancer therapies and select appropriate diagnostic strategies. - 3	Recognize common cardiovascular complications associated with contemporary cancer therapies and select appropriate diagnostic strategies. - 2	Recognize common cardiovascular complications associated with contemporary cancer therapies and select appropriate diagnostic strategies. - 1
Develop multidisciplinary management approaches that minimize cardiovascular risk while supporting the delivery of effective cancer treatment.	Develop multidisciplinary management approaches that minimize cardiovascular risk while supporting the delivery of effective cancer treatment. - 5	Develop multidisciplinary management approaches that minimize cardiovascular risk while supporting the delivery of effective cancer treatment. - 4	Develop multidisciplinary management approaches that minimize cardiovascular risk while supporting the delivery of effective cancer treatment. - 3	Develop multidisciplinary management approaches that minimize cardiovascular risk while supporting the delivery of effective cancer treatment. - 2	Develop multidisciplinary management approaches that minimize cardiovascular risk while supporting the delivery of effective cancer treatment. - 1

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence NA|Not applicable to my practice

	5	4	3	2	1
Describe the role of cardiovascular risk assessment and surveillance before, during and after cancer treatment.	Describe the role of cardiovascular risk assessment and surveillance before, during and after cancer treatment. - 5	Describe the role of cardiovascular risk assessment and surveillance before, during and after cancer treatment. - 4	Describe the role of cardiovascular risk assessment and surveillance before, during and after cancer treatment. - 3	Describe the role of cardiovascular risk assessment and surveillance before, during and after cancer treatment. - 2	Describe the role of cardiovascular risk assessment and surveillance before, during and after cancer treatment. - 1
Recognize common cardiovascular complications associated with contemporary cancer therapies.	Recognize common cardiovascular complications associated with contemporary cancer therapies. - 5	Recognize common cardiovascular complications associated with contemporary cancer therapies. - 4	Recognize common cardiovascular complications associated with contemporary cancer therapies. - 3	Recognize common cardiovascular complications associated with contemporary cancer therapies. - 2	Recognize common cardiovascular complications associated with contemporary cancer therapies. - 1
Develope multidisciplinary management approaches that minimize cardiovascular risk while supporting the delivery of effective cancer treatment.	Develope multidisciplinary management approaches that minimize cardiovascular risk while supporting the delivery of effective cancer treatment. - 5	Develope multidisciplinary management approaches that minimize cardiovascular risk while supporting the delivery of effective cancer treatment. - 4	Develope multidisciplinary management approaches that minimize cardiovascular risk while supporting the delivery of effective cancer treatment. - 3	Develope multidisciplinary management approaches that minimize cardiovascular risk while supporting the delivery of effective cancer treatment. - 2	Develope multidisciplinary management approaches that minimize cardiovascular risk while supporting the delivery of effective cancer treatment. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so?

Please provide any additional comments or suggestions.

Name and ABS ID Required to claim MOC *

You are here

HWCI - Multispecialty Grand Rounds Evaluation - September 14, 2026